Company Filing History:
Years Active: 2016-2022
Title: The Innovative Contributions of Dorin Toader
Introduction
Dorin Toader is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. With a total of 4 patents to his name, Toader's work focuses on advancing medical treatments, especially in oncology.
Latest Patents
One of Toader's latest patents is titled "Methods for preparing antibodies with a defined glycosylation pattern." This patent describes a process for creating antibodies that possess a specific glycosylation pattern, particularly those with a glycan terminating in N-acetylglucosamine. These antibodies are designed for use in conjugating therapeutic payloads, making them valuable in cancer treatment. Another significant patent is for "Tubulysin derivatives," which presents novel tubulysin derivatives that may serve as cytotoxic agents. These derivatives are intended to provide therapeutic benefits in treating various types of cancers, either alone or in combination with other chemotherapies.
Career Highlights
Dorin Toader is currently employed at MedImmune Limited, where he continues to innovate and contribute to the field of biotechnology. His work at MedImmune has positioned him as a key player in the development of new therapeutic strategies.
Collaborations
Toader has collaborated with several talented individuals in his field, including Lakshmaiah Gingipalli and Fengjiang Wang. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Dorin Toader's contributions to biotechnology, particularly in the development of cancer therapies, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.